PA
Palisade Bio, Inc.
PALI · NASDAQ
$2.05 -5.75% (-$0.13)
1M -4.21%
Market Cap $355.8M
P/E Ratio -
Div. Yield -
ROE 33.47%
Bulios Fair Price
$1.2
41.5% downside
Trenutna cena
$2.05
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PALI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
34 /100
Fair P/S 711.68x
P/B 2.92x
P/E N/A
Growth
100 /100
Growing Book val. growth 118.05%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 3,638.00%
Net margin 6,388.20%
Quality
0 /100
Poor ROIC 28.96%
Asset turnover 0.00x
ROE 33.47%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -5,536.67x
Current ratio 24.26x
Stability
11 /100
Unstable Beta 1.55x
Profitable years 0
EPS volatility 84.41%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PALI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. D. Finley
Employees
14
Headquarters
Denver
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report